Successful Desensitization to Sorafenib and Imatinib—A Report of Two Cases and a Literature Review

Background: Drug desensitization allows for safe administration of a drug to a patient with a previous hypersensitivity reaction. Successful desensitization protocols have been described for different medications, including protocols for oncology patients. Few cases of desensitization to sorafenib a...

Full description

Bibliographic Details
Main Authors: Natasa Kusic, Vesna Tomic Spiric, Snezana Arandjelovic, Aleksandra Peric Popadic, Ivana Bozic Antic, Milan Dimitrijevic, Rada Miskovic, Ljiljana Stefanovic, Aleksandra Plavsic
Format: Article
Language:English
Published: MDPI AG 2024-03-01
Series:Healthcare
Subjects:
Online Access:https://www.mdpi.com/2227-9032/12/6/601
_version_ 1797240797566861312
author Natasa Kusic
Vesna Tomic Spiric
Snezana Arandjelovic
Aleksandra Peric Popadic
Ivana Bozic Antic
Milan Dimitrijevic
Rada Miskovic
Ljiljana Stefanovic
Aleksandra Plavsic
author_facet Natasa Kusic
Vesna Tomic Spiric
Snezana Arandjelovic
Aleksandra Peric Popadic
Ivana Bozic Antic
Milan Dimitrijevic
Rada Miskovic
Ljiljana Stefanovic
Aleksandra Plavsic
author_sort Natasa Kusic
collection DOAJ
description Background: Drug desensitization allows for safe administration of a drug to a patient with a previous hypersensitivity reaction. Successful desensitization protocols have been described for different medications, including protocols for oncology patients. Few cases of desensitization to sorafenib and imatinib have been described in the literature so far. Objective: The objective of this paper is to describe the process of the sorafenib and imatinib drug hypersensitivity diagnosis and desensitization process in two patients. Methods: Two oncology patients who experienced non-immediate hypersensitivity reactions to sorafenib and imatinib underwent desensitization to these drugs. We designed a protocol for the first patient and used a modified protocol from the literature for the second patient. Results: By using a slow desensitization technique and gradual tapering of corticosteroids and antihistamines, both patients reached the target dose of the incriminated drug. Conclusions: Desensitization to sorafenib and imatinib can be an effective therapeutic option in patients with hypersensitivity to those medications, without alternative treatment options.
first_indexed 2024-04-24T18:13:09Z
format Article
id doaj.art-133884af5ff746b3a6a45b785581a459
institution Directory Open Access Journal
issn 2227-9032
language English
last_indexed 2024-04-24T18:13:09Z
publishDate 2024-03-01
publisher MDPI AG
record_format Article
series Healthcare
spelling doaj.art-133884af5ff746b3a6a45b785581a4592024-03-27T13:43:33ZengMDPI AGHealthcare2227-90322024-03-0112660110.3390/healthcare12060601Successful Desensitization to Sorafenib and Imatinib—A Report of Two Cases and a Literature ReviewNatasa Kusic0Vesna Tomic Spiric1Snezana Arandjelovic2Aleksandra Peric Popadic3Ivana Bozic Antic4Milan Dimitrijevic5Rada Miskovic6Ljiljana Stefanovic7Aleksandra Plavsic8Clinic of Allergy and Immunology, University Clinical Centre of Serbia, 11000 Beograd, SerbiaClinic of Allergy and Immunology, University Clinical Centre of Serbia, 11000 Beograd, SerbiaClinic of Allergy and Immunology, University Clinical Centre of Serbia, 11000 Beograd, SerbiaClinic of Allergy and Immunology, University Clinical Centre of Serbia, 11000 Beograd, SerbiaEuromedik Healthcare System, 11158 Belgrade, SerbiaClinic of Allergy and Immunology, University Clinical Centre of Serbia, 11000 Beograd, SerbiaClinic of Allergy and Immunology, University Clinical Centre of Serbia, 11000 Beograd, SerbiaClinic of Allergy and Immunology, University Clinical Centre of Serbia, 11000 Beograd, SerbiaClinic of Allergy and Immunology, University Clinical Centre of Serbia, 11000 Beograd, SerbiaBackground: Drug desensitization allows for safe administration of a drug to a patient with a previous hypersensitivity reaction. Successful desensitization protocols have been described for different medications, including protocols for oncology patients. Few cases of desensitization to sorafenib and imatinib have been described in the literature so far. Objective: The objective of this paper is to describe the process of the sorafenib and imatinib drug hypersensitivity diagnosis and desensitization process in two patients. Methods: Two oncology patients who experienced non-immediate hypersensitivity reactions to sorafenib and imatinib underwent desensitization to these drugs. We designed a protocol for the first patient and used a modified protocol from the literature for the second patient. Results: By using a slow desensitization technique and gradual tapering of corticosteroids and antihistamines, both patients reached the target dose of the incriminated drug. Conclusions: Desensitization to sorafenib and imatinib can be an effective therapeutic option in patients with hypersensitivity to those medications, without alternative treatment options.https://www.mdpi.com/2227-9032/12/6/601desensitizationdrug hypersensitivity reactionimatinibsorafenib
spellingShingle Natasa Kusic
Vesna Tomic Spiric
Snezana Arandjelovic
Aleksandra Peric Popadic
Ivana Bozic Antic
Milan Dimitrijevic
Rada Miskovic
Ljiljana Stefanovic
Aleksandra Plavsic
Successful Desensitization to Sorafenib and Imatinib—A Report of Two Cases and a Literature Review
Healthcare
desensitization
drug hypersensitivity reaction
imatinib
sorafenib
title Successful Desensitization to Sorafenib and Imatinib—A Report of Two Cases and a Literature Review
title_full Successful Desensitization to Sorafenib and Imatinib—A Report of Two Cases and a Literature Review
title_fullStr Successful Desensitization to Sorafenib and Imatinib—A Report of Two Cases and a Literature Review
title_full_unstemmed Successful Desensitization to Sorafenib and Imatinib—A Report of Two Cases and a Literature Review
title_short Successful Desensitization to Sorafenib and Imatinib—A Report of Two Cases and a Literature Review
title_sort successful desensitization to sorafenib and imatinib a report of two cases and a literature review
topic desensitization
drug hypersensitivity reaction
imatinib
sorafenib
url https://www.mdpi.com/2227-9032/12/6/601
work_keys_str_mv AT natasakusic successfuldesensitizationtosorafenibandimatinibareportoftwocasesandaliteraturereview
AT vesnatomicspiric successfuldesensitizationtosorafenibandimatinibareportoftwocasesandaliteraturereview
AT snezanaarandjelovic successfuldesensitizationtosorafenibandimatinibareportoftwocasesandaliteraturereview
AT aleksandrapericpopadic successfuldesensitizationtosorafenibandimatinibareportoftwocasesandaliteraturereview
AT ivanabozicantic successfuldesensitizationtosorafenibandimatinibareportoftwocasesandaliteraturereview
AT milandimitrijevic successfuldesensitizationtosorafenibandimatinibareportoftwocasesandaliteraturereview
AT radamiskovic successfuldesensitizationtosorafenibandimatinibareportoftwocasesandaliteraturereview
AT ljiljanastefanovic successfuldesensitizationtosorafenibandimatinibareportoftwocasesandaliteraturereview
AT aleksandraplavsic successfuldesensitizationtosorafenibandimatinibareportoftwocasesandaliteraturereview